Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomohiko Ohta

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
Nature Cell Biology|May 6, 2010
A mitotic role for the DNA damage-responsive CHK2 kinaseKo Sato, Tomohiko Ohta, Ashok R Venkitaraman
Nihon Geka Gakkai Zasshi|December 14, 2002
[Breast-conserving surgery: quadrantectomy]Hisanori Kawamoto, Haruki Ogata, Tomohiko Ohta, et al.
Cell Division|January 9, 2008
The ubiquitin E3 ligase activity of BRCA1 and its biological functionsWenwen Wu, Ayaka Koike, Takashi Takeshita, et al.
Breast Cancer (Tokyo, Japan)|August 4, 2021
Molecular targeted drugs resistance impairs double-strand break repair and sensitizes ER-positive breast cancer to PARP inhibitorsYuna Suzuki, Wu Wenwen, Tomohiko Ohta, et al.
Cancer Science|June 15, 2020
FBXO22, an epigenetic multiplayer coordinating senescence, hormone signaling, and metastasisYoshikazu Johmura, Alexander S Harris, Tomohiko Ohta, et al.
Frontiers in Immunology|October 12, 2023
Editorial: Community series in post-translational modifications of proteins in cancer immunity and immunotherapy, volume IINaoe Taira Nihira, Tomohiko Ohta, Zichuan Liu, et al.
Nature Cell Biology|September 28, 2004
Targeted ubiquitination of CDT1 by the DDB1-CUL4A-ROC1 ligase in response to DNA damageJian Hu, Chad M McCall, Tomohiko Ohta, et al.
Breast Cancer (Tokyo, Japan)|August 22, 2021
Correction to: Molecular targeted drugs resistance impairs double‑strand break repair and sensitizes ER‑positive breast cancer to PARP inhibitorsYuna Suzuki, Wu Wenwen, Tomohiko Ohta, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2009
Perturbation of DNA repair pathways by proteasome inhibitors corresponds to enhanced chemosensitivity of cells to DNA damage-inducing agentsTakashi Takeshita, Wenwen Wu, Ayaka Koike, et al.
Biochemical and Biophysical Research Communications|August 2, 2002
Targeted substrate degradation by an engineered double RING ubiquitin ligaseDaisuke Oyake, Hiroyuki Nishikawa, Izumi Koizuka, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Nature Cell Biology|May 6, 2010
A mitotic role for the DNA damage-responsive CHK2 kinaseKo Sato, Tomohiko Ohta, Ashok R Venkitaraman
Nihon Geka Gakkai Zasshi|December 14, 2002
[Breast-conserving surgery: quadrantectomy]Hisanori Kawamoto, Haruki Ogata, Tomohiko Ohta, et al.
Cell Division|January 9, 2008
The ubiquitin E3 ligase activity of BRCA1 and its biological functionsWenwen Wu, Ayaka Koike, Takashi Takeshita, et al.
Breast Cancer (Tokyo, Japan)|August 4, 2021
Molecular targeted drugs resistance impairs double-strand break repair and sensitizes ER-positive breast cancer to PARP inhibitorsYuna Suzuki, Wu Wenwen, Tomohiko Ohta, et al.
Cancer Science|June 15, 2020
FBXO22, an epigenetic multiplayer coordinating senescence, hormone signaling, and metastasisYoshikazu Johmura, Alexander S Harris, Tomohiko Ohta, et al.
Frontiers in Immunology|October 12, 2023
Editorial: Community series in post-translational modifications of proteins in cancer immunity and immunotherapy, volume IINaoe Taira Nihira, Tomohiko Ohta, Zichuan Liu, et al.
Nature Cell Biology|September 28, 2004
Targeted ubiquitination of CDT1 by the DDB1-CUL4A-ROC1 ligase in response to DNA damageJian Hu, Chad M McCall, Tomohiko Ohta, et al.
Breast Cancer (Tokyo, Japan)|August 22, 2021
Correction to: Molecular targeted drugs resistance impairs double‑strand break repair and sensitizes ER‑positive breast cancer to PARP inhibitorsYuna Suzuki, Wu Wenwen, Tomohiko Ohta, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2009
Perturbation of DNA repair pathways by proteasome inhibitors corresponds to enhanced chemosensitivity of cells to DNA damage-inducing agentsTakashi Takeshita, Wenwen Wu, Ayaka Koike, et al.
Biochemical and Biophysical Research Communications|August 2, 2002
Targeted substrate degradation by an engineered double RING ubiquitin ligaseDaisuke Oyake, Hiroyuki Nishikawa, Izumi Koizuka, et al.
Pageof 8